Ambar Protein Industries Limited has published its unaudited financial results for the third quarter of fiscal year 2026, demonstrating continued operational performance in the refined cottonseed oil business. The company reported comprehensive financial metrics for both quarterly and nine-month periods ended December 31, 2025.

Financial Performance Overview

The company's latest financial results reveal mixed performance compared to the previous year. Key financial metrics for the reporting period are presented below:

Board Meeting and Regulatory Compliance

The Board of Directors convened on February 2, 2026, from 3:30 PM to 4:10 PM to approve the financial results. The meeting resulted in formal approval of both the unaudited financial results and the limited review auditors' report for the quarter and nine months ended December 31, 2025.

Newspaper Publication Requirements

In compliance with Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the company published newspaper clippings of its financial results on February 3, 2026. The publication details are summarized below:

Company Information

Ambar Protein Industries Limited maintains its equity share capital at ₹575 lacs with face value of ₹10 per share. The company operates from Plot No. 351, 353, 358, opposite Bhagyoday Hotel, Sarkhej-Bavla Highway, Changodar, Ahmedabad district, Gujarat, and trades on BSE Limited under scrip code 519471.

Ambar Protein Industries has witnessed multiple stake increases by its promoter through open market transactions in December. Minouli Pradeepbhai Khetani has made two separate acquisitions during the month, as disclosed under SEBI regulations.

Recent Transaction Details

The promoter's latest acquisition involved 2,488 equity shares representing 0.04% of the company's total share capital through open market transactions on December 19, 2025. This follows an earlier acquisition of 5,177 shares on December 9, 2025.

Shareholding Pattern Evolution

The cumulative acquisitions have resulted in a progressive increase in the promoter's total shareholding in the company. The promoter's stake has increased from 9.54% to 9.67% through these December transactions.

Company's Share Capital Structure

Ambar Protein Industries Limited maintains a consistent equity share capital structure throughout these transactions. The company's total equity share capital remains unchanged at ₹5.75 crores, consisting of 57,50,000 equity shares of ₹10 each.

The company's shares are listed on BSE Limited under scrip code 519471. The total diluted share capital also stands at ₹5.75 crores, consisting of 57,50,000 equity shares of ₹10 each, indicating no outstanding convertible securities or warrants.

Regulatory Compliance

Both disclosures were made in compliance with SEBI regulations governing substantial acquisition of shares and takeovers under Regulation 29(2). The promoter fulfilled the mandatory disclosure requirements by notifying both BSE Limited and the company about the transactions within the stipulated timeframe. This transparency ensures that all stakeholders are informed about changes in the promoter's shareholding pattern.